Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Measure Oral bioavailability Published finding 38.4% in rats What it means Shows that some oral absorption occurred in that model
Dein Erfolg ist auch mein Erfolg
Safety cannot be established outside of controlled laboratory research
Second-line treatments, known as device-aided therapies (DATs), have been developed for LDRCs, such as continuous subcutaneous apomorphine infusion (CSAI), continuous subcutaneous foslevodopafoscarbidopa, infusion of levodopacarbidopa intestinal gel (LCIG entacapone) and subthalamic deep brain stimulation
.png.jpg)
US$ 27.30
US$ 27.28
US$ 20.93
US$ 22.99
US$ 27.08
US$ 24.81
US$ 21.76
US$ 27.97
